Medworxx Solutions Inc. the Corporation has retained the services of New-York based Berkery, Noyes & Co., LLC (“BNC”) as its advisor as it explores strategic alternatives to maximize shareholder value.
Strategic and financial alternatives pursued with BNC may include, but are not limited to, the sale of the Corporation, acquisitions by the Corporation, merger or other business combination, recapitalization, sale of all or a portion of the Corporation’s assets, or any combination thereof, as well as continued execution of its business plan, among all other alternatives.
It is the Corporation’s current intention not to disclose developments with respect to the strategic review process until the Board of Directors has approved a specific transaction or otherwise determines that disclosure is necessary or appropriate. Medworxx cautions that there are no assurances or guarantees that the process will result in a transaction or, if a transaction is undertaken, the terms or timing of such a transaction.
About Medworxx
Medworxx delivers health information solutions to over 350 hospitals internationally; including Canada, United States and United Kingdom. Medworxx helps hospitals meet patient flow challenges and requirements in compliance and education. Medworxx Clinical Criteria– flagship of Medworxx Patient Flow that includes electronic bed board and independent assessment components – currently serves over 34% of the acute care beds in Canada. Founded in 2004, Medworxx is based in Toronto, Ontario and publicly traded on the TSX Venture Exchange: MWX. Visit: www.medworxx.com
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.
Forward Looking Statements Disclaimer
This press release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or “recurring” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as competition, technological changes, the changing needs of hospitals, the financial condition of the Company’s current and potential customers, foreign currency exchange rates, as well as general economic conditions, which may cause the actual results, performance or achievements of the Corporation and Medworxx to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this press release. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
SOURCE: Medworxx Solutions Inc.
Medworxx Solutions Inc.
Dan Matlow, 416-642-1278 Ext. 311
President & Chief Executive Officer
dmatlow@medworxx.com
or
Brian Goffenberg, 416-642-1278 Ext. 315
Chief Financial Officer & Executive Vice President
bgoffenberg@medworxx.com
or
Berkery Noyes
Thomas P. O’Connor, 646-442-7994
Managing Director
tom@berkerynoyes.com
